Charles River Laboratories International, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRL research report →
Companywww.criver.com
Charles River Laboratories International, Inc. , a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing).
- CEO
- James C. Foster
- IPO
- 2000
- Employees
- 18,700
- HQ
- Wilmington, MA, US
Price Chart
Valuation
- Market Cap
- $7.46B
- P/E
- -41.06
- P/S
- 1.85
- P/B
- 2.58
- EV/EBITDA
- 12.84
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 31.86%
- Op Margin
- 11.77%
- Net Margin
- -4.59%
- ROE
- -5.74%
- ROIC
- 7.14%
Growth & Income
- Revenue
- $4.02B · -0.85%
- Net Income
- $-144,338,000 · -1501.75%
- EPS
- $-2.91 · -1555.00%
- Op Income
- $507.84M
- FCF YoY
- 3.37%
Performance & Tape
- 52W High
- $228.88
- 52W Low
- $132.58
- 50D MA
- $168.04
- 200D MA
- $175.92
- Beta
- 1.45
- Avg Volume
- 982.28K
Get TickerSpark's AI analysis on CRL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 12, 26 | Andrews Nancy C | other | 3,964 |
| May 12, 26 | Andrews Nancy C | other | 3,964 |
| May 8, 26 | Barg Steven | other | 1,438 |
| May 8, 26 | Thompson Craig B. | other | 1,438 |
| May 8, 26 | Graves Paul W | other | 1,438 |
| May 8, 26 | Ceesay Abraham | other | 1,438 |
| May 8, 26 | MACKAY MARTIN | other | 1,407 |
| May 8, 26 | MACKAY MARTIN | other | 1,438 |
| May 8, 26 | Andrews Nancy C | other | 1,438 |
| May 8, 26 | Llado George Sr. | other | 450 |
Our CRL Coverage
We haven't published any research on CRL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CRL Report →